Integra LifeSciences IART United States — Total Revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's united states — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's united states — total revenues?
- Integra LifeSciences (IART) reported united states — total revenues of $289.38M in Q1 2026.
- How has Integra LifeSciences's united states — total revenues changed year-over-year?
- Integra LifeSciences's united states — total revenues increased by 2.5% year-over-year, from $282.22M to $289.38M.
- What is the long-term trend for Integra LifeSciences's united states — total revenues?
- Over 4 years (2021 to 2025), Integra LifeSciences's united states — total revenues has grown at a 2.5% compound annual growth rate (CAGR), from $1.09B to $1.2B.
- What does united states — total revenues mean?
- This metric represents the total net revenue generated from products and services sold within the United States geographic market. It serves as a primary indicator of the company's domestic market penetration and demand for its medical technology portfolio. Tracking this figure allows investors to assess the performance of the core domestic business segment relative to international operations.